Phase I Pharmacokinetic Study of Nivolumab in Korean Patients with Advanced Solid Tumors

LESSONS LEARNED. This pharmacokinetic study of nivolumab showed that there is little ethnic difference in the handling of nivolumab. Nivolumab was well tolerated in Korean patients. BACKGROUND. This phase I study of nivolumab, an anti‐programmed cell death‐1 (anti‐PD‐1) monoclonal antibody, investig...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncologist
Main Authors: Lee, Keun‐Wook, Lee, Dae Ho, Kang, Jin Hyoung, Park, Joon Oh, Kim, Se Hyun, Hong, Yong Sang, Kim, Seung Tae, Oh, Do‐Youn, Bang, Yung‐Jue
Format: Artigo
Sprog:Inglês
Udgivet: AlphaMed Press 2017
Fag:
Clinical Trial Results
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5813749/
https://ncbi.nlm.nih.gov/pubmed/29158363
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0528
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker